Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

[Valorisation of brachytherapy and medico-economic considerations].

Pommier P, Morelle M, Millet-Lagarde F, Peiffert D, Gomez F, Perrier L.

Cancer Radiother. 2013 Apr;17(2):178-81. doi: 10.1016/j.canrad.2013.02.004. Epub 2013 Apr 16. Review. French.

PMID:
23601252
2.

[Cost comparison of three treatments for localized prostate cancer in Spain: radical prostatectomy, prostate brachytherapy and external 3D conformal radiotherapy].

Becerra Bachino V, Cots F, Guedea F, Pera J, Boladeras A, Aguiló F, Suárez JF, Gallo P, Murgui L, Pont A, Cunillera O, Pardo Y, Ferrer M; Grupo Multicéntrico Español de Cáncer de Próstata Organoconfinado.

Gac Sanit. 2011 Jan-Feb;25(1):35-43. doi: 10.1016/j.gaceta.2010.10.008. Spanish.

3.

Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study.

Buron C, Le Vu B, Cosset JM, Pommier P, Peiffert D, Delannes M, Flam T, Guerif S, Salem N, Chauveinc L, Livartowski A.

Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):812-22.

PMID:
17293235
4.

Cost comparison of curative therapies for localized prostate cancer in Japan: a single-institution experience.

Satoh T, Ishiyama H, Matsumoto K, Tabata K, Kitano M, Iwamura M, Kimura M, Minamida S, Yamashita H, Matsuda D, Kotani S, Niibe Y, Uemae M, Hayakawa K, Baba S.

Jpn J Radiol. 2009 Nov;27(9):348-54. doi: 10.1007/s11604-009-0356-x. Epub 2009 Nov 27.

PMID:
19943145
5.

[Permanent implant prostate cancer brachytherapy: 2013 state-of-the art].

Cosset JM, Hannoun-Lévi JM, Peiffert D, Delannes M, Pommier P, Pierrat N, Nickers P, Thomas L, Chauveinc L.

Cancer Radiother. 2013 Apr;17(2):111-7. doi: 10.1016/j.canrad.2013.01.009. Epub 2013 Mar 9. Review. French.

PMID:
23478488
6.

Cost implications of the rapid adoption of newer technologies for treating prostate cancer.

Nguyen PL, Gu X, Lipsitz SR, Choueiri TK, Choi WW, Lei Y, Hoffman KE, Hu JC.

J Clin Oncol. 2011 Apr 20;29(12):1517-24. doi: 10.1200/JCO.2010.31.1217. Epub 2011 Mar 14.

7.

[Clinical and dosimetric analysis of 469 prostate cancer patients treated in France in 2005 by permanent implant brachytherapy using the Iodin 125 seeds IsoSeed Bebig: report to the French Economic committee of health products (CEPS)].

Cosset JM, Gomme S, Peiffert D, Guerif S, Labib A, Hannoun-Lévi JM, Martin P, Quétin P, Nguyen TD, Flam T, Thiounn N, Henni M, Rosenwald JC, Housset M, Pontvert D, Asselain B, Chauveinc L.

Cancer Radiother. 2007 Jun;11(4):206-13. Epub 2007 Jun 28. French.

PMID:
17604675
8.

[Quality control in pulsed dose rate brachytherapy].

Métayer Y, Meyer P, Brunaud C, Peiffert D.

Cancer Radiother. 2009 Jul;13(4):318-22. doi: 10.1016/j.canrad.2009.02.005. Epub 2009 May 7. French.

PMID:
19427253
9.
10.

[Economic assessment of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution for cervix carcinoma].

Remonnay R, Morelle M, Pommier P, Haie-Meder C, Quetin P, Kerr C, Delannes M, Castelain B, Peignaux K, Kirova Y, Romestaing P, Williaume D, Krzisch C, Thomas L, Lang P, Baron MH, Cussac A, Lesaunier F, Maillard S, Barillot I, Charra-Brunaud C, Carrère MO, Peiffert D.

Cancer Radiother. 2010 Jun;14(3):161-8. doi: 10.1016/j.canrad.2009.11.004. Epub 2010 Mar 4. French.

PMID:
20206571
11.

[Benefit assessment by the Federal Joint Committee: assessment of treatment strategies for low risk prostate cancer].

Schmedders M, Janatzek S, Zimmer B.

Urologe A. 2011 Aug;50(8):938-43. doi: 10.1007/s00120-011-2545-3. German.

PMID:
21720836
12.

Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer.

Shah C, Lanni TB Jr, Ghilezan MI, Gustafson GS, Marvin KS, Ye H, Vicini FA, Martinez AA.

Brachytherapy. 2012 Nov-Dec;11(6):441-5. doi: 10.1016/j.brachy.2012.04.002. Epub 2012 Jun 23.

PMID:
22728157
13.

The technique of 125I permanent implants.

Maurer U, Eble MJ.

Front Radiat Ther Oncol. 2002;36:159-65. Review. No abstract available.

PMID:
11842746
14.

[Development and perspectives of brachytherapy in France].

Peiffert D, Hannoun-Lévi JM.

Cancer Radiother. 2013 Apr;17(2):76-80. doi: 10.1016/j.canrad.2013.03.002. Epub 2013 Apr 11. Review. French.

PMID:
23583231
15.

Cost comparison of radical prostatectomy and transperineal brachytherapy for localized prostate cancer.

Ciezki JP, Klein EA, Angermeier KW, Ulchaker J, Zippe CD, Wilkinson DA.

Urology. 2000 Jan;55(1):68-72.

PMID:
10654897
16.

A comparative costs analysis of brachytherapy and radical retropubic prostatectomy therapies for clinically localized prostate cancer.

Gianino MM, Galzerano M, Minniti D, Di Novi C, Martin B, Davini O, Barbaro S.

Int J Technol Assess Health Care. 2009 Jul;25(3):411-4. doi: 10.1017/S0266462309990043. Review.

PMID:
19619361
17.

Perioperative costs and charges of prostate brachytherapy and prostatectomy.

Makhlouf AA, Boyd JC, Chapman TN, Theodorescu D.

Urology. 2002 Oct;60(4):656-60.

PMID:
12385928
18.

[Acting in concert: comments on the article by M. Schmedders et al on different therapy approaches for prostate cancer with low risks].

Stöckle M.

Urologe A. 2011 Aug;50(8):944-5. doi: 10.1007/s00120-011-2641-4. German. No abstract available.

PMID:
21720830
19.

A comparison of the cost of various treatment methods for early cancer of the prostate.

Hanks GE, Dunlap K.

Int J Radiat Oncol Biol Phys. 1986 Oct;12(10):1879-81.

PMID:
3759540
20.

Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness.

Norderhaug I, Dahl O, Høisaeter PA, Heikkilä R, Klepp O, Olsen DR, Kristiansen IS, Waehre H, Bjerklund Johansen TE.

Eur Urol. 2003 Jul;44(1):40-6. Review.

PMID:
12814673
Items per page

Supplemental Content

Write to the Help Desk